Outcomes of initial and repeat micro-pulse transscleral cyclophotocoagulation in adult glaucoma patients.
Sara J HooshmandJackson VossMatthew HirabayashiLindsey McDanielJella AnPublished in: Therapeutic advances in ophthalmology (2022)
MP-TSCPC is a safe and effective non-invasive means to lower IOP in a variety of glaucoma patients. While over 50% (34/67) of eyes required repeat MP-TSCPC, repeat treatment resulted in greater success rates and IOP reduction without any adverse events when using the total energy between 112 and 150 J.